Astronics Corp
ATRO Nasdaq Aircraft Parts & Auxiliary Equipment, Nec Financials FY2016βFY2025
What Astronics Corp does
No business description yet.
- Legal name
- ASTRONICS CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0000008063-26-000021
0000008063
Revenue and margins
Astronics Corp had $862M of revenue in fiscal 2025, up 8.4% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β5.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $43.1M in fiscal 2025, 5.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Astronics Corp returned β to shareholders in fiscal 2025. The diluted share count rose 4.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Astronics Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $29.8M | $13.8M | $4.8M | $9.3M | $18.2M |
| Debt incl. finance leases | $163M | $164M | $168M | $169M | $334M |
| Net debt / EBITDA | 402.8x | β | 8.4x | 3.1x | 3.2x |
| Debt / equity | 0.6x | 0.7x | 0.7x | 0.7x | 2.4x |
| Current ratio | 2.9x | 2.4x | 2.7x | 2.7x | 3.1x |
| Quick ratio | 1.5x | 1.2x | 1.4x | 1.5x | 1.7x |
| Total assets | $609M | $615M | $634M | $649M | $707M |
| Total liabilities | $353M | $375M | $384M | $393M | $567M |
| Shareholders' equity | $257M | $240M | $250M | $256M | $140M |
| Net debt (β = net cash) | $133M | $150M | $164M | $160M | $316M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 9 | 8 / 9 | 5 / 9 | 4 / 9 | 3 / 9 | 3 / 9 | 6 / 9 | 7 / 9 | 6 / 9 |
| Accruals ratio | β0.1% | β2.7% | β1.1% | 1.2% | β21.8% | β3.3% | β1.2% | β0.4% | β7.3% | β6.7% |
| Altman Z'' | 5.64 | 4.48 | 5.27 | 4.70 | 3.73 | 4.37 | 3.90 | 4.24 | 4.66 | 4.74 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $633M | $624M | $803M | $773M | $503M | $445M | $535M | $689M | $795M | $862M |
| Net interest income | β$4.4M | β$5.4M | β$9.7M | β$6.1M | β$6.7M | β$6.8M | β$9.4M | β$23.3M | β | β |
| Gross profit | $159M | $137M | $181M | $156M | $96.8M | $65.4M | $71.5M | $175M | $220M | $258M |
| Research and development | $88.9M | $95.0M | $114M | $109M | $40.2M | $43.3M | $48.3M | $53.7M | $52.1M | $43.5M |
| Operating income | $74.9M | $32.1M | $63.7M | $1.7M | β$101M | β$28.7M | β$30.0M | β$6.7M | $26.5M | $76.4M |
| Pretax income | $68.8M | $25.0M | $52.3M | $68.3M | β$112M | β$27.0M | β$29.8M | β$26.3M | β$7.9M | $31.9M |
| Income tax | $20.4M | $5.3M | $5.5M | $16.3M | $3.4M | β$1.4M | $6.0M | $0.1M | $8.3M | $2.6M |
| Net income | $48.4M | $19.7M | $46.8M | $52.0M | β$116M | β$25.6M | β$35.7M | β$26.4M | β$16.2M | $29.4M |
| Diluted EPS | $1.40 | $0.58 | $1.41 | $1.60 | β$3.76 | β$0.82 | β$1.11 | β$0.80 | β$0.46 | $0.81 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $48.9M | $37.8M | $54.9M | $42.7M | $37.3M | β$5.5M | β$28.3M | β$24.0M | $30.6M | $74.8M |
| Capital expenditure | $13.0M | $13.5M | $16.3M | $12.1M | $7.5M | $6.0M | $7.7M | $7.6M | $8.4M | $31.7M |
| Free cash flow | $35.8M | $24.3M | $38.6M | $30.6M | $29.9M | β$11.6M | β$36.0M | β$31.6M | $22.1M | $43.1M |
| Depreciation and amortization | $25.8M | $27.1M | $35.0M | $33.0M | $31.9M | $29.0M | $27.8M | $26.1M | $24.5M | $21.8M |
| Stock-based compensation | $2.3M | $2.6M | $3.1M | $3.8M | $5.2M | $6.5M | $6.5M | $7.2M | $8.6M | $6.8M |
| Acquisitions | $0.0M | $114M | $0.0M | $28.9M | $0.0M | $0.0M | β | $0.0M | $0.0M | $22.1M |
| Share buybacks | $17.6M | $32.4M | $0.0M | $50.8M | $7.7M | $0.0M | $0.0M | β | β | β |
| Dividends and buybacks | $17.6M | $32.4M | $0.0M | $50.8M | $7.7M | $0.0M | $0.0M | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $17.9M | $17.9M | $16.6M | $31.9M | $40.4M | $29.8M | $13.8M | $4.8M | $9.3M | $18.2M |
| Total debt | $148M | $272M | $234M | $188M | $173M | $163M | $164M | $168M | $169M | $334M |
| Finance lease liabilities | β | β | β | $4.7M | $2.8M | $0.1M | $0.1M | $0.2M | $0.1M | β |
| Current assets | $255M | $315M | $374M | $343M | $317M | $340M | $365M | $390M | $426M | $438M |
| Current liabilities | $86.6M | $103M | $128M | $121M | $93.7M | $119M | $152M | $143M | $156M | $141M |
| Inventory | $117M | $150M | $139M | $146M | $157M | $158M | $188M | $192M | $200M | $197M |
| Property and equipment, net | $123M | $126M | $121M | $112M | $107M | $95.2M | $90.7M | $85.4M | $80.7M | $107M |
| Goodwill | $115M | $126M | $125M | $145M | $58.3M | $58.3M | $58.2M | $58.2M | $58.1M | $62.9M |
| Intangible assets | $98.1M | $153M | $133M | $127M | $110M | $94.3M | $79.3M | $65.4M | $52.5M | $55.4M |
| Total assets | $604M | $736M | $775M | $783M | $620M | $609M | $615M | $634M | $649M | $707M |
| Total liabilities | $267M | $406M | $388M | $394M | $349M | $353M | $375M | $384M | $393M | $567M |
| Shareholders' equity | $337M | $330M | $387M | $389M | $270M | $257M | $240M | $250M | $256M | $140M |
| Margins | ||||||||||
| Gross margin | 25.2% | 22.0% | 22.5% | 20.2% | 19.3% | 14.7% | 13.4% | 25.3% | 27.7% | 29.9% |
| Operating margin | 11.8% | 5.1% | 7.9% | 0.2% | β20.0% | β6.4% | β5.6% | β1.0% | 3.3% | 8.9% |
| EBITDA margin | 15.9% | 9.5% | 12.3% | 4.5% | β13.7% | 0.1% | β0.4% | 2.8% | 6.4% | 11.4% |
| Net margin | 7.6% | 3.2% | 5.8% | 6.7% | β23.0% | β5.7% | β6.7% | β3.8% | β2.0% | 3.4% |
| FCF margin | 5.7% | 3.9% | 4.8% | 4.0% | 5.9% | β2.6% | β6.7% | β4.6% | 2.8% | 5.0% |
| Net interest share of revenue | β0.7% | β0.9% | β1.2% | β0.8% | β1.3% | β1.5% | β1.8% | β3.4% | β | β |
| Returns | ||||||||||
| Return on capital | 11.3% | 4.3% | 9.4% | 0.2% | β19.7% | β5.8% | β6.1% | β1.3% | 5.0% | 15.4% |
| Return on capital employed | 14.5% | 5.1% | 9.8% | 0.3% | β19.1% | β5.8% | β6.5% | β1.4% | 5.4% | 13.5% |
| Return on equity | 14.4% | 5.9% | 13.1% | 13.4% | β35.1% | β9.7% | β14.4% | β10.8% | β6.4% | 14.8% |
| Return on assets | 8.0% | 2.9% | 6.2% | 6.7% | β16.5% | β4.2% | β5.8% | β4.2% | β2.5% | 4.3% |
| Return on tangible equity | 39.0% | 38.7% | 36.5% | 44.6% | β113.3% | β24.6% | β34.9% | β21.0% | β11.1% | 134.7% |
| Growth | ||||||||||
| Revenue growth | β | β1.4% | 28.6% | β3.8% | β35.0% | β11.5% | 20.2% | 28.8% | 15.4% | 8.4% |
| Net income growth | β | β59.4% | 137.8% | 11.1% | β322.6% | β | β | β | β | β |
| EPS growth | β | β58.6% | 143.1% | 13.5% | β335.0% | β | β | β | β | β |
| FCF growth | β | β32.1% | 58.7% | β20.6% | β2.4% | β138.7% | β | β | β | 94.8% |
| Share count change | β | β2.4% | β1.7% | β2.0% | β5.1% | 0.9% | 3.6% | 2.9% | 5.8% | 4.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.3x | 4.3x | 2.2x | 4.6x | β | 402.8x | β | 8.4x | 3.1x | 3.2x |
| Debt / equity | 0.4x | 0.8x | 0.6x | 0.5x | 0.6x | 0.6x | 0.7x | 0.7x | 0.7x | 2.4x |
| Current ratio | 2.9x | 3.1x | 2.9x | 2.8x | 3.4x | 2.9x | 2.4x | 2.7x | 2.7x | 3.1x |
| Quick ratio | 1.6x | 1.6x | 1.8x | 1.6x | 1.7x | 1.5x | 1.2x | 1.4x | 1.5x | 1.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.1% | 2.2% | 2.0% | 1.6% | 1.5% | 1.4% | 1.4% | 1.1% | 1.1% | 3.7% |
| Stock comp / revenue | 0.4% | 0.4% | 0.4% | 0.5% | 1.0% | 1.5% | 1.2% | 1.0% | 1.1% | 0.8% |
| Payouts / FCF | 49.2% | 133.2% | 0.0% | 165.9% | 25.9% | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 8.0 | 5.0 | 4.0 | 3.0 | 3.0 | 6.0 | 7.0 | 6.0 |
| Altman Z'' | 5.6 | 4.5 | 5.3 | 4.7 | 3.7 | 4.4 | 3.9 | 4.2 | 4.7 | 4.7 |
| Accruals ratio | β0.1% | β2.7% | β1.1% | 1.2% | β21.8% | β3.3% | β1.2% | β0.4% | β7.3% | β6.7% |
Source: SEC EDGAR XBRL filings (CIK 0000008063). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.